TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06428006

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia
Description: The general sessions outlines are as follows with each session:~Session 1: determine treatment plan, set up sleep schedule and stimulus control, discuss strategies for how to stay awake to prescribed hour and what to do if wake up in middle of night, sleep hygiene education Session 2: continue upward titration of total sleep time, review sleep hygiene; introduce diaphragmatic breathing Session 3: continue upward titration of total sleep time, introduce mindfulness Session 4: continue upward titration of total sleep time, introduce progressive muscle relaxation Session 5: continue upward titration of total sleep time, discuss negative sleep beliefs Session 6: assess global treatment gains, discuss relapse prevention

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep and lifestyle education
Description: The general sessions outlines are as follows with each session:~Session 1: Basic sleep education, stretching exercises Session 2: Sleep hygiene education (environmental factors \& sleep positions), stretching exercises Session 3: Sleep hygiene education (lifestyle factors), stretching exercises Session 4: Diet recommendations, stretching exercises Session 5: Exercises recommendations, stretching exercises Session 6: Discus maintaining achievements \& preventing relapses, stretching exercises
Study: NCT06083051

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 6Fr Percuflex ureteral stents
Description: The Percuflex stent is a 6Fr polymeric, hydrophilic coated stent that is routinely used post ureteroscopy with laser lithotripsy.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 6Fr Tria ureteral stents
Description: The Tria stent is a new stent that is designed to soften at body temperature after placement, with an additional coating that prevents calcium and magnesium build up. This is intended to increase patient tolerability of the stent. 6 Fr is the diameter.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 4.8Fr Tria ureteral stents
Description: The Tria stent is a new stent that is designed to soften at body temperature after placement, with an additional coating that prevents calcium and magnesium build up. This is intended to increase patient tolerability of the stent. 4.8 Fr is the diameter.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 4.8Fr Percuflex ureteral stents
Description: The Percuflex stent is a 4.8Fr polymeric, hydrophilic coated stent that is routinely used post ureteroscopy with laser lithotripsy.
Study: NCT06552377

Intervention type: DEVICE
Intervention: Ultrasound Attenuation imaging measurement
Description: Participant to undergo conventional ultrasound scanning with attenuation measurement as well.
Study: NCT06669858

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual therapy
Description: In first session 6 techniques were applied to favorise fluids circulation, respiratory mecanism end equilibration of pressions (all were external soft tissue techniques, without manipulation): on cervico dorsal hinge, on cranial diaphragm, on thoracic diaphragm, on pelvic diaphram, on liver and spleen organ, on lumbar fasciae.~In second session 6 techniques were applied in order to improve quality and quantity of legs and pelvis mobility (all were external sof tissue techniques, without manipulation) : on cervico dorsal hinge, on cranial diaphragm, on thoracic diaphragm, on pelvic diaphram, on pubic symphysis, on legs and pelvis and on lumbar fasciae

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Wide ligth touch pressure applied with the 2 hand at day 2-4 and day 90
Study: NCT05097378

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Encorafenib + Binimetinib
Description: Encorafenib is a potent and highly selective ATP-competitive small molecule RAF kinase inhibitor, which suppresses the RAF/MEK/ERK pathway in tumour cells expressing several mutated forms of BRAF kinase (V600E, D and K).~Binimetinib is an ATP-uncompetitive, reversible inhibitor of the kinase activity of mitogen-activated extracellular signal regulated kinase 1 (MEK1) and MEK2. Binimetinib inhibits activation of MEK by BRAF and inhibits MEK kinase activity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard Adjuvant Treatment
Description: Standard Adjuvant Treatment
Study: NCT04924114

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-6194
Description: Subcutaneous injection

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: MK-6194-matching placebo
Description: Subcutaneous injection
Study: NCT06312774

Intervention type: OTHER
Intervention: This is observational study
Description: This is observational study

Intervention type: OTHER
Intervention: This is observational study
Description: This is observational study
Study: NCT06218888

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab 200mg，D1, Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fruquintinib
Description: Fruquintinib 3mg ,D1-D14, Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide
Description: Chidamide 30mg
Study: NCT05245617

Intervention type: DEVICE
Intervention: JuniOrtho™ Plating System™
Description: The patient underwent surgery for the application of JPS for treatment of deformity or traumatic fracture.
Study: NCT05448768

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TBS for Amyloid-positive MCI
Description: The investigators will perform standard intermittent TBS (iTBS) parameters to left DLPFC of every patient in the study. The frequency parameters of TBS are 3-pulse 50-Hz bursts, every 200 ms at 5 Hz, and the intensity is 90% of active motor threshold. A single session of iTBS contains 2 s of TBS repeated every 10 s for 20 times. In this study, The investigators will give two sessions of iTBS separated by 15 min.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TBS for Amyloid-negative MCI
Description: The investigators will perform standard intermittent TBS (iTBS) parameters to left DLPFC of every patient in the study. The frequency parameters of TBS are 3-pulse 50-Hz bursts, every 200 ms at 5 Hz, and the intensity is 90% of active motor threshold. A single session of iTBS contains 2 s of TBS repeated every 10 s for 20 times. In this study, The investigators will give two sessions of iTBS separated by 15 min.
Study: NCT05385471

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Matrix M with R78C and/or RH5.1
Description: 50 µg of Matrix-M adjuvant with R78C and/or RH5.1 at different doses and timepoints

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Matrix M with R78C and/or RH5.1
Description: 50 µg of Matrix-M adjuvant with R78C and/or RH5.1 at different doses and timepoints

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Matrix M with R78C and/or RH5.1
Description: 50 µg of Matrix-M adjuvant with R78C and/or RH5.1 at different doses and timepoints

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Matrix M with R78C and/or RH5.1
Description: 50 µg of Matrix-M adjuvant with R78C and/or RH5.1 at different doses and timepoints
Study: NCT06112405

Intervention type: OTHER
Group type: OTHER
Intervention: App-based CCAAP
Description: App-based CCAAP, could remind patients take controller and reliever when asthma symptoms get worse through mobile.

Intervention type: OTHER
Group type: OTHER
Intervention: Written CCAAP
Description: Written CCAAP, conventional management for patients with asthma, remind them take controller and reliever when asthma symptoms get worse.
Study: NCT05949216

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Musical engagement sessions
Description: Musical engagement sessions will be 2 hours long and involve improvisation and sight-reading of sheet music. Participants will supply their own instrument of choice to play. There will be four sessions total.
Study: NCT06500299

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HDM1002 100 mg QD
Description: HDM1002 tablets 100mg daily, 12weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HDM1002 200 mg QD 12weeks
Description: HDM1002 tablets 200mg daily, 12weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HDM1002 400 mg QD 12weeks
Description: HDM1002 tablets 400mg daily, 12weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo will be provided
Study: NCT04613414

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early Management
Description: Scheduled for sleep physician appointment within 1 month of home sleep apnea test/triage
Study: NCT05035901

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: visual-perception motor-coordination integration program
Description: Visual-perception motor-coordination integration program (CCVPMCI) is a Chinese characteristic-based VMI-focused program involving the most Chinese-handwriting-related skills training. CCVPMCI mainly emphasizes the training role of visual-motor integration. The idea of CCVPMCI program will involve (1) visual motor integration training affiliated with visual perception and motor coordination as warm-up exercise, (2) more focus on visual spatial perception in connect with unique visual structure of Chinese characters, (3) the trace or component elements of Chinese characters as the interesting practice material and (4) appropriate challenge for learning.
Study: NCT06669052

Intervention type: DIETARY_SUPPLEMENT
Intervention: 30 mg liposomal iron, capsules
Description: a dietary supplement capsule, of mainly 30 mg liposomal iron, and Vitamin C 70mg, vitamin D3 400IU, vitamin B6 1.75 mcg, Folate 1000 mcg, b=vitamin B12 10 mcg. all in capsulated in 1 Hard gelatin capsule
Study: NCT05382416

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SHARE! Peer Toolkit Training
Description: The SHARE! Peer Toolkit training is designed to improve the performance of peer workers in their provision of peer support. The training covers each of the 12 tools in the Peer Toolkit, which are taught through brief presentations followed by group discussions and interactive exercises to help people competently use each of the tools. Training sessions are typically two hours each, three times per week for 10 weeks.
Study: NCT05353335

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Re-timing of anti-hypertensive drug
Description: The intervention will consist of shifting the anti-hypertensive medication from morning/early dose to an evening/later dose

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Current regimen
Description: The participants will begin on their current regimen.
Study: NCT06161909

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sintilimab
Description: 200mg fixed dose Q3W,1 year
Study: NCT05459844

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lutetium[177Lu] Oxodotreotide Injection
Description: Four administrations of 7.4 GBq (200 mCi) Lutetium\[177Lu\] Oxodotreotide Injection administered at 8 +/- 1-week intervals, which could be extended up to 16 weeks to accommodate resolving acute toxicity.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Octreotide LAR
Description: 60 mg Octreotide LAR treatment was given to the participants every 4 weeks (i.m. injections) until the end of the study, unless the participant progressed or died.
Study: NCT06398353

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Description: Real acupuncture twice a week for two weeks

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Real acupuncture
Description: Real acupuncture twice a week for two weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham acupuncture
Description: Sham acupuncture twice a week for two weeks
Study: NCT05359926

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Early urethral foley removal after the surgery

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active comparator
Description: Delayed urethral foley removal after the surgery
Study: NCT06398353

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham acupuncture
Description: Sham acupuncture twice a week for two weeks
Study: NCT06537986

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurocognitive and psychosocial intervention module
Description: The module comprised of various intervention methods that include- I. Cognitive Retraining: Pen-and-paper-based cognitive rehabilitation program that is divided into five hierarchically graded modules: Attention, Visual Processing, Memory, Information Processing, and Executive Functions.~2.Cognitive-behavioral interventions. Cognitive-behavioral interventions would be carried out for activities scheduling, problem-solving teachings, anger management techniques, modifications of negative cognitions, stigma address measures, and irrational beliefs about epilepsy, etc.~3. Marital/Family counseling: Marital/family counseling would be done to ensure family understanding of the patient's illness, his/her treatment, prognosis, and outcome. Family complications arising due to illness would also be discussed. Individual and personal needs of the husband, a wife will also be discussed.
Study: NCT05827367

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: The high-power pain threshold ultrasound (HPPTUS) In this technique, which be applied in continuous mode with intensity from t0.5 to 2 watt/cm to elicit pain threshold the US probe was kept motionless, and the intensity progressively increased until the maximum level of pain patient can endure was selected, it was maintained on this level for 3 to 4 seconds and then decreased to half intensity for 15 seconds the treatment process was repeated three times.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial release technique
Description: Plantar fascia myofascial release Soluse muscle myofascial release Gastrocnmias muscle myofascial release

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Strength and stretching
Description: Plantar fascia stretching Interstice foot muscles strengthing

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength and stretching
Description: Plantar fascia stretching Interstice foot muscles strengthing

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength and stretching
Description: Plantar fascia stretching Interstice foot muscles strengthing
Study: NCT04744077

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Influencer Instagram account
Description: Participants randomized to this group will follow a public Instagram account. This account was chosen because they have a strong following (over 600,000 followers) and it is a public account that anyone can follow. The content shared on this page is motivational and community driven. There is a focus of healthy living with an emphasis on exercise. Additionally, there are no paid sponsorships or radical exercise advice, which is common on other influencer pages. The Co-PIs determined that this page accurately represents the exercise-related content that is readily available on Instagram. The research team will not have control over the content of this account, but the account holder will be notified about the study.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Research study Instagram account
Description: Intervention arms will deliver the same exercise-related content on the same schedule on the intervention Instagram accounts. The arms will deliver 13-weeks worth of content which goes through the last possible day of the intervention. The structure was based on feedback from stakeholders in a formative focus group. All of the content delivered through the accounts is evidence-based and referenced from reputation organizations/agencies such as the American College of Sports Medicine, American Heart Association, Center for Disease Control, and World Health Organization. Each Co-PI will post videos to answer participant questions. To ensure that the content between both groups is the same, the Co-PIs will meet to determine which questions to answer and draft the response.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Research study Instagram account
Description: Intervention arms will deliver the same exercise-related content on the same schedule on the intervention Instagram accounts. The arms will deliver 13-weeks worth of content which goes through the last possible day of the intervention. The structure was based on feedback from stakeholders in a formative focus group. All of the content delivered through the accounts is evidence-based and referenced from reputation organizations/agencies such as the American College of Sports Medicine, American Heart Association, Center for Disease Control, and World Health Organization. Each Co-PI will post videos to answer participant questions. To ensure that the content between both groups is the same, the Co-PIs will meet to determine which questions to answer and draft the response.
Study: NCT05776485

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Description: Only the control group: 3 exercise bouts within the study period. Comparison between exercised and non-exercised leg.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cross-sectional comparison between healthy and tendinopathic group
Description: Comparison of primary and secondary outcomes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cross-sectional comparison between healthy and tendinopathic group
Description: Comparison of primary and secondary outcomes.
Study: NCT04987671

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMX0035
Description: Fixed dose combination of Sodium Phenylbutyrate and taurursodiol.
Study: NCT06309147

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-9894923
Description: 50 mg capsules, oral administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-9894923
Description: 50 mg capsules, oral administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: BMS-9894923
Description: 50 mg capsules, oral administration
Study: NCT05031910

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical Device Usage and Evaluation
Description: Undergo virtual reality imaging via VR/3D-CEPs

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Practice
Description: Receive standard of care

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive standard of care

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resection
Description: Undergo surgical resection

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Resection
Description: Undergo surgical resection
Study: NCT06280365

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Mobilization with Movement Technique
Description: Mobilization Technique
Study: NCT06168708

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Description: TURP with addition of gentamicin on irrigation fluid to reduce infectious complications

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Description: TURP with addition of gentamicin on irrigation fluid to reduce infectious complications

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gentamicin
Description: gentamicin 80 mg (2ml) /3L of irrigation solution (the first 9 Liters during resection and the first 6 Liters during post-operative irrigation)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: normal saline (2 ml) on the irrigation solution (placebo)
Study: NCT06182865

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ga-68 Dolacga Injection
Description: Ga-68 Dolacga will be administered via iv bolus injection followed by a whole-body PET/CT scan for liver reserve evaluation.
Study: NCT06349902

Intervention type: BEHAVIORAL
Intervention: Re-Link
Description: The HCV nurse will attempt to contact the PWDU HCV via phone call and text. If unable to connect with a client via phone, an alert is added to the client's chart in the electronic medical record. When the client presents to the CBSUTP for their regular substance use follow up appointment, the chart alert is flagged by the administrative team and the client is connected with the HCV nurse via telemedicine. Clients who are connected to the HCV team are considered re-linked. The HCV nurse will provide an HCV intake as per program guidelines. Clients who would prefer to pursue treatment elsewhere will be supported with a referral to their family doctor or an alternative HCV program in the community. Clients who choose to be treated at the CBSUTP will receive a HCV consultation, DAA treatment and follow-up from the HCV clinical team onsite as per existing program guidelines.
Study: NCT05476224

Intervention type: BIOLOGICAL
Intervention: Blood sample of 30 ml
Description: The parameters analyzed on this blood sample: Fasting blood glucose, HbA1C, creatinine, creatinine clearance (MDRD), fasting lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides.

Intervention type: BIOLOGICAL
Intervention: Blood sample of 30 ml
Description: The parameters analyzed on this blood sample: Fasting blood glucose, HbA1C, creatinine, creatinine clearance (MDRD), fasting lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides.

Intervention type: BIOLOGICAL
Intervention: Blood sample of 30 ml
Description: The parameters analyzed on this blood sample: Fasting blood glucose, HbA1C, creatinine, creatinine clearance (MDRD), fasting lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides.

Intervention type: BIOLOGICAL
Intervention: Blood sample of 30 ml
Description: The parameters analyzed on this blood sample: Fasting blood glucose, HbA1C, creatinine, creatinine clearance (MDRD), fasting lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides.
Study: NCT05869305

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: whey protein isolate
Description: Take 1 sachet/day for 12 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: isolated soy protein
Description: Take 1 sachet/day for 12 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: placebo
Description: Take 1 sachet/day for 12 weeks.
Study: NCT06149338

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Description: Macintosh laryngoscope has been the gold standard for endotracheal intubation since the middle of 20th century. During laryngoscopy and direct vision of the vocal cords, an endotracheal tube is passed into the trachea, establishing the airway.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vie Scope
Description: Vie Scope is a laryngoscope, whose function is relied on Seldinger technique. Firstly, bougie is passed through the translucent barrel of Vie Scope under direct vision between the vocal cords and into the trachea. Then, Vie Scope is removed and an endotracheal tube is passed over the bougie, which will be finally removed. The inflation of the endotracheal tube's cuff is followed by ventilation and confirmation of the tube placement.